{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:12:08Z","timestamp":1794507128193,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15235-0","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:45:22Z","timestamp":1764942322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retrospective analysis of the clinical features and prognosis of idiopathic pulmonary fibrosis combined with lung cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Shoushuo","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"9","key":"15235_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"15235_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s41030-023-00216-0","volume":"9","author":"H Alsomali","year":"2023","unstructured":"Alsomali H, Palmer E, Aujayeb A, Funston W. Early diagnosis and treatment of idiopathic pulmonary fibrosis: a narrative review. Pulm Ther. 2023;9(2):177\u201393.","journal-title":"Pulm Ther"},{"issue":"6","key":"15235_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S2213-2600(19)30059-1","volume":"7","author":"G Raghu","year":"2019","unstructured":"Raghu G, Flaherty KR, Lederer DJ, Lynch DA, Colby TV, Myers JL, et al. Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study. Lancet Respir Med. 2019;7(6):487\u201396.","journal-title":"Lancet Respir Med"},{"key":"15235_CR4","doi-asserted-by":"crossref","unstructured":"Caminati A, Lonati C, Cassandro R, Elia D, Pelosi G, Torre O, et al. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respir Rev. 2019;28(153):190044.","DOI":"10.1183\/16000617.0044-2019"},{"issue":"3","key":"15235_CR5","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"15235_CR6","doi-asserted-by":"crossref","unstructured":"MA AL MAAL, Hamouri S, Al-Shaikh AF, Haddad HK, Al-Quran WY, MM AL, et al. Epidemiology and histopathological classification of lung cancer: A study from Jordan, retrospective observational study. Ann Med Surg (Lond). 2021;65:102330.","DOI":"10.1016\/j.amsu.2021.102330"},{"key":"15235_CR7","doi-asserted-by":"crossref","unstructured":"Czy\u017cak B, Majewski S. Concomitant idiopathic pulmonary fibrosis and lung cancer: an updated narrative review. Adv Respiratory Med. 2025;93(4):93\u2013101.","DOI":"10.3390\/arm93040031"},{"key":"15235_CR8","doi-asserted-by":"crossref","unstructured":"Ballester B, Milara J, Cortijo J. Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets. Int J Mol Sci. 2019;20(3):593.","DOI":"10.3390\/ijms20030593"},{"key":"15235_CR9","doi-asserted-by":"crossref","unstructured":"Kinoshita T, Goto T. Molecular mechanisms of pulmonary fibrogenesis and its progression to lung cancer: A review. Int J Mol Sci. 2019;20(6):1461.","DOI":"10.3390\/ijms20061461"},{"key":"15235_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.830340","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu L, Ding M, He W. Emerging therapeutic strategies for attenuating tubular EMT and kidney fibrosis by targeting Wnt\/\u03b2-catenin signaling. Front Pharmacol. 2021;12:830340.","journal-title":"Front Pharmacol"},{"key":"15235_CR11","doi-asserted-by":"crossref","unstructured":"Iksen PS, Pongrakhananon V. Targeting the PI3K\/AKT\/mTOR signaling pathway in lung cancer: an update regarding potential drugs and natural products. Molecules. 2021;26(13):4100.","DOI":"10.3390\/molecules26134100"},{"key":"15235_CR12","doi-asserted-by":"crossref","unstructured":"Samarelli AV, Masciale V, Aramini B, Col\u00f3 GP, Tonelli R, Marchioni A, et al. Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. Int J Mol Sci. 2021;22(22):12179.","DOI":"10.3390\/ijms222212179"},{"issue":"6","key":"15235_CR13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/ndt\/gfaa301","volume":"37","author":"L Landolt","year":"2022","unstructured":"Landolt L, Spagnoli GC, Hertig A, Brocheriou I, Marti HP. Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches. Nephrol Dial Transplant. 2022;37(6):1024\u201332.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"15235_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1165\/rcmb.2019-0172ED","volume":"61","author":"PA Reyfman","year":"2019","unstructured":"Reyfman PA, Gottardi CJ. Idiopathic pulmonary fibrosis and lung cancer: finding similarities within differences. Am J Respir Cell Mol Biol. 2019;61(6):667\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"15235_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01791-z","volume":"22","author":"TM Maher","year":"2021","unstructured":"Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res. 2021;22(1):197.","journal-title":"Respir Res"},{"issue":"17","key":"15235_CR16","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.3760\/cma.j.issn.0366-6999.20141346","volume":"127","author":"J Li","year":"2014","unstructured":"Li J, Yang M, Li P, Su Z, Gao P, Zhang J. Idiopathic pulmonary fibrosis will increase the risk of lung cancer. Chin Med J (Engl). 2014;127(17):3142\u20139.","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"15235_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255375","volume":"16","author":"H Alomaish","year":"2021","unstructured":"Alomaish H, Ung Y, Wang S, Tyrrell PN, Zahra SA, Oikonomou A. Survival analysis in lung cancer patients with interstitial lung disease. PLoS ONE. 2021;16(9):e0255375.","journal-title":"PLoS ONE"},{"issue":"2","key":"15235_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4143\/crt.2017.119","volume":"50","author":"WI Choi","year":"2018","unstructured":"Choi WI, Park SH, Park BJ, Lee CW. Interstitial lung disease and lung cancer development: a 5-year nationwide population-based study. Cancer Res Treat. 2018;50(2):374\u201381.","journal-title":"Cancer Res Treat"},{"issue":"2","key":"15235_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.chest.2019.04.114","volume":"156","author":"A Tzouvelekis","year":"2019","unstructured":"Tzouvelekis A, Gomatou G, Bouros E, Trigidou R, Tzilas V, Bouros D. Common pathogenic mechanisms between idiopathic pulmonary fibrosis and lung cancer. Chest. 2019;156(2):383\u201391.","journal-title":"Chest"},{"key":"15235_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2019.101880","volume":"60","author":"A Tzouvelekis","year":"2020","unstructured":"Tzouvelekis A, Karampitsakos T, Gomatou G, Bouros E, Tzilas V, Manali E, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. A retrospective multicenter study in Greece. Pulm Pharmacol Ther. 2020;60:101880.","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"15235_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0905-8","volume":"19","author":"H Yoo","year":"2019","unstructured":"Yoo H, Jeong BH, Chung MJ, Lee KS, Kwon OJ, Chung MP. Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulm Med. 2019;19(1):149.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"15235_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1440-1843.2009.01547.x","volume":"14","author":"Y Ozawa","year":"2009","unstructured":"Ozawa Y, Suda T, Naito T, Enomoto N, Hashimoto D, Fujisawa T, et al. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology. 2009;14(5):723\u20138.","journal-title":"Respirology"},{"key":"15235_CR23","doi-asserted-by":"crossref","unstructured":"Kato E, Takayanagi N, Takaku Y, Kagiyama N, Kanauchi T, Ishiguro T, et al. Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2018;4(1):00111\u20132016.","DOI":"10.1183\/23120541.00111-2016"},{"issue":"1","key":"15235_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1378\/chest.14-0359","volume":"147","author":"S Tomassetti","year":"2015","unstructured":"Tomassetti S, Gurioli C, Ryu JH, Decker PA, Ravaglia C, Tantalocco P, et al. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. Chest. 2015;147(1):157\u201364.","journal-title":"Chest"},{"issue":"2","key":"15235_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/1559325820923828","volume":"18","author":"R Huang","year":"2020","unstructured":"Huang R, Liu X, He L, Zhou PK. Radiation exposure associated with computed tomography in childhood and the subsequent risk of cancer: a meta-analysis of cohort studies. Dose Response. 2020;18(2):1559325820923828.","journal-title":"Dose Response"},{"issue":"5","key":"15235_CR26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41893-024-01323-9","volume":"7","author":"R Wang","year":"2024","unstructured":"Wang R, Yang S, Wang M, Zhou Y, Li X, Chen W, et al. A sustainable approach to universal metabolic cancer diagnosis. Nat Sustain. 2024;7(5):602\u201315.","journal-title":"Nat Sustain"},{"key":"15235_CR27","doi-asserted-by":"crossref","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary Fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368.","DOI":"10.1164\/rccm.201807-1255ST"},{"issue":"10299","key":"15235_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398(10299):535\u201354.","journal-title":"Lancet"},{"issue":"9","key":"15235_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/jech.2006.051292","volume":"61","author":"K Heikkila","year":"2007","unstructured":"Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61(9):824\u201333.","journal-title":"J Epidemiol Community Health"},{"key":"15235_CR30","doi-asserted-by":"crossref","unstructured":"Muller DC, Larose TL, Hodge A, Guida F, Langhammer A, Grankvist K, et al. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within lung cancer cohort consortium. BMJ. 2019;364:k4981.","DOI":"10.1136\/bmj.k4981"},{"issue":"1","key":"15235_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02309-x","volume":"24","author":"K Zhang","year":"2023","unstructured":"Zhang K, Li A, Zhou J, Zhang C, Chen M. Genetic association of circulating C-reactive protein levels with idiopathic pulmonary fibrosis: a two-sample Mendelian randomization study. Respir Res. 2023;24(1):7.","journal-title":"Respir Res"},{"key":"15235_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720876","volume":"12","author":"S Si","year":"2021","unstructured":"Si S, Li J, Tewara MA, Xue F. Genetically determined chronic low-grade inflammation and hundreds of health outcomes in the UK biobank and the FinnGen population: a phenome-wide Mendelian randomization study. Front Immunol. 2021;12:720876.","journal-title":"Front Immunol"},{"issue":"1","key":"15235_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01866-x","volume":"22","author":"DA Newton","year":"2021","unstructured":"Newton DA, Lottes RG, Ryan RM, Spyropoulos DD, Baatz JE. Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue. Respir Res. 2021;22(1):278.","journal-title":"Respir Res"},{"key":"15235_CR34","doi-asserted-by":"crossref","unstructured":"Yan P, Liu J, Li Z, Wang J, Zhu Z, Wang L, et al. Glycolysis reprogramming in idiopathic pulmonary fibrosis: unveiling the mystery of lactate in the lung. Int J Mol Sci. 2023;25(1):10315.","DOI":"10.3390\/ijms25010315"},{"issue":"3215","key":"15235_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O. On respiratory impairment in cancer cells. Science. 1956;124(3215):269\u201370.","journal-title":"Science"},{"issue":"3","key":"15235_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ijc.31069","volume":"142","author":"S Rodic","year":"2018","unstructured":"Rodic S, Vincent MD. Reactive oxygen species (ROS) are a key determinant of cancer\u2019s metabolic phenotype. Int J Cancer. 2018;142(3):440\u20138.","journal-title":"Int J Cancer"},{"key":"15235_CR37","doi-asserted-by":"crossref","unstructured":"Varma G, Seth P, Coutinho de Souza P, Callahan C, Pinto J, Vaidya M, et al. Visualizing the effects of lactate dehydrogenase (LDH) Inhibition and LDH-A genetic ablation in breast and lung cancer with hyperpolarized pyruvate NMR. NMR Biomed. 2021;34(8):e4560.","DOI":"10.1002\/nbm.4560"},{"issue":"8","key":"15235_CR38","volume":"12","author":"S Mohamed","year":"2020","unstructured":"Mohamed S, Abdelhaffez A, Abd El-Aziz N. Serum procalcitonin in patients with combined lung cancer and idiopathic pulmonary fibrosis (LC-IPF). Cureus. 2020;12(8):e9507.","journal-title":"Cureus"},{"issue":"1","key":"15235_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1871526515666150320162950","volume":"15","author":"V Avrillon","year":"2015","unstructured":"Avrillon V, Locatelli-Sanchez M, Folliet L, Carbonnaux M, Perino E, Fossard G, et al. Lung cancer may increase serum procalcitonin level. Infectious Disorders. 2015;15(1):57\u201363.","journal-title":"Infectious Disorders"},{"issue":"11","key":"15235_CR40","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3889\/oamjms.2018.421","volume":"6","author":"NN Soeroso","year":"2018","unstructured":"Soeroso NN, Tanjung MF, Afiani D, Pradana A, Tarigan SP, Wahyuni AS. Procalcitonin level in non-small cell lung cancer patients among Indonesian population. Open Access Maced J Med Sci. 2018;6(11):2123\u20137.","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"15235_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0792-z","volume":"19","author":"Y Guo","year":"2019","unstructured":"Guo Y, Ying S, Zhao X, Liu J, Wang Y. Increased expression of lung TRPV1\/TRPA1 in a cough model of bleomycin-induced pulmonary fibrosis in Guinea pigs. BMC Pulm Med. 2019;19(1):27.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"15235_CR42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/annonc\/mdp332","volume":"21","author":"MJ Duffy","year":"2010","unstructured":"Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, et al. Tumor markers in pancreatic cancer: a European group on tumor markers (EGTM) status report. Ann Oncol. 2010;21(3):441\u20137.","journal-title":"Ann Oncol"},{"key":"15235_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2017.12.020","volume":"194","author":"ZF Jiang","year":"2018","unstructured":"Jiang ZF, Wang M, Xu JL. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Life Sci. 2018;194:1\u20136.","journal-title":"Life Sci"},{"key":"15235_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.686313","volume":"8","author":"Z Jiao","year":"2021","unstructured":"Jiao Z, Cao S, Li J, Hu N, Gong Y, Wang L, et al. Clinical associations of preoperative and postoperative serum CEA and lung cancer outcome. Front Mol Biosci. 2021;8:686313.","journal-title":"Front Mol Biosci"},{"issue":"8","key":"15235_CR45","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1440-1843.2012.02231.x","volume":"17","author":"A Fahim","year":"2012","unstructured":"Fahim A, Crooks MG, Wilmot R, Campbell AP, Morice AH, Hart SP. Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis. Respirology. 2012;17(8):1247\u201352.","journal-title":"Respirology"},{"key":"15235_CR46","doi-asserted-by":"crossref","unstructured":"d\u2019Alessandro M, Bergantini L, Torricelli E, Cameli P, Lavorini F, Pieroni M, et al. Systematic review and metanalysis of oncomarkers in IPF patients and serial changes of oncomarkers in a prospective Italian Real-Life case series. Cancers (Basel). 2021;13(3):539.","DOI":"10.3390\/cancers13030539"},{"key":"15235_CR47","doi-asserted-by":"crossref","unstructured":"Xu CM, Luo YL, Li S, Li ZX, Jiang L, Zhang GX, et al. Multifunctional neuron-specific enolase: its role in lung diseases. Biosci Rep. 2019;39(11):BSR20192131.","DOI":"10.1042\/BSR20192732"},{"issue":"16","key":"15235_CR48","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.7150\/ijms.58415","volume":"18","author":"L Lu","year":"2021","unstructured":"Lu L, Zha Z, Zhang P, Li D, Liu G. NSE, positively regulated by LINC00657-miR-93-5p axis, promotes small cell lung cancer (SCLC) invasion and epithelial-mesenchymal transition (EMT) process. Int J Med Sci. 2021;18(16):3768\u201379.","journal-title":"Int J Med Sci"},{"key":"15235_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9845123","volume":"2018","author":"ZQ Chen","year":"2018","unstructured":"Chen ZQ, Huang LS, Zhu B. Assessment of seven clinical tumor markers in diagnosis of non-small-cell lung cancer. Dis Markers. 2018;2018:9845123.","journal-title":"Dis Markers"},{"issue":"12","key":"15235_CR50","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1164\/rccm.202107-1769OC","volume":"205","author":"PL Molyneaux","year":"2022","unstructured":"Molyneaux PL, Fahy WA, Byrne AJ, Braybrooke R, Saunders P, Toshner R, et al. CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort. Am J Respir Crit Care Med. 2022;205(12):1440\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"15235_CR51","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1007\/s00432-023-04727-w","volume":"149","author":"H Zheng","year":"2023","unstructured":"Zheng H, Nie D, Huang X. Association between idiopathic pulmonary fibrosis and risk of different pathological types of lung cancer: a Mendelian randomization study. J Cancer Res Clin Oncol. 2023;149(10):7751\u20137.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"15235_CR52","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1002\/ijc.33499","volume":"148","author":"A Hata","year":"2021","unstructured":"Hata A, Nakajima T, Matsusaka K, Fukuyo M, Nakayama M, Morimoto J, et al. Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis. Int J Cancer. 2021;148(12):3008\u201318.","journal-title":"Int J Cancer"},{"issue":"1","key":"15235_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01711-1","volume":"22","author":"F Luppi","year":"2021","unstructured":"Luppi F, Kalluri M, Faverio P, Kreuter M, Ferrara G. Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management. Respir Res. 2021;22(1):109.","journal-title":"Respir Res"},{"issue":"1","key":"15235_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/resp.14363","volume":"28","author":"T Karampitsakos","year":"2023","unstructured":"Karampitsakos T, Spagnolo P, Mogulkoc N, Wuyts WA, Tomassetti S, Bendstrup E, et al. Lung cancer in patients with idiopathic pulmonary fibrosis: a retrospective multicentre study in Europe. Respirology. 2023;28(1):56\u201365.","journal-title":"Respirology"},{"key":"15235_CR55","doi-asserted-by":"crossref","unstructured":"Prieto LI, Sturmlechner I, Graves SI, Zhang C, Goplen NP, Yi ES, et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell. 2023;41(7):1261\u2013e12751266.","DOI":"10.1016\/j.ccell.2023.05.006"},{"key":"15235_CR56","doi-asserted-by":"crossref","unstructured":"Parimon T, Hohmann MS, Yao C. Cellular senescence: pathogenic mechanisms in lung fibrosis. Int J Mol Sci. 2021;22(12):6214.","DOI":"10.3390\/ijms22126214"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15235-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:45:27Z","timestamp":1764942327000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15235-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15235"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15235-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7551547\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved (approval no. 2024010) by the Medical Ethics Committee of Yueyang Hospital Affiliated to Hunan Normal University (Yueyang, China). Written informed consent to participate was obtained from all participants included in this study. The research was conducted in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients provided consent for the publication of their data and associated images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1854"}}